290 related articles for article (PubMed ID: 28752351)
1. The clinical use of neutrophil-to-lymphocyte ratio in bladder cancer patients: a systematic review and meta-analysis.
Tang X; Du P; Yang Y
Int J Clin Oncol; 2017 Oct; 22(5):817-825. PubMed ID: 28752351
[TBL] [Abstract][Full Text] [Related]
2. Preoperative neutrophil-lymphocyte ratio can significantly predict mortality outcomes in patients with non-muscle invasive bladder cancer undergoing transurethral resection of bladder tumor.
Kang M; Jeong CW; Kwak C; Kim HH; Ku JH
Oncotarget; 2017 Feb; 8(8):12891-12901. PubMed ID: 28039452
[TBL] [Abstract][Full Text] [Related]
3. Validation of Neutrophil-to-lymphocyte Ratio in a Multi-institutional Cohort of Patients With T1G3 Non-muscle-invasive Bladder Cancer.
Vartolomei MD; Ferro M; Cantiello F; Lucarelli G; Di Stasi S; Hurle R; Guazzoni G; Busetto GM; De Berardinis E; Damiano R; Perdona S; Verze P; La Rocca R; Borghesi M; Schiavina R; Brunocilla E; Almeida GL; Bove P; Lima E; Grimaldi G; Autorino R; Crisan N; Abu Farhan AR; Battaglia M; Serretta V; Russo GI; Morgia G; Terracciano D; Musi G; de Cobelli O; Mirone V; Shariat SF
Clin Genitourin Cancer; 2018 Dec; 16(6):445-452. PubMed ID: 30077463
[TBL] [Abstract][Full Text] [Related]
4. Pretreatment Neutrophil-Lymphocyte Ratio as a Predictor in Bladder Cancer and Metastatic or Unresectable Urothelial Carcinoma Patients: a Pooled Analysis of Comparative Studies.
Wu S; Zhao X; Wang Y; Zhong Z; Zhang L; Cao J; Ai K; Xu R
Cell Physiol Biochem; 2018; 46(4):1352-1364. PubMed ID: 29689562
[TBL] [Abstract][Full Text] [Related]
5. Prognostic role of pretreatment neutrophil-to-lymphocyte ratio (NLR) in patients with non-muscle-invasive bladder cancer (NMIBC): A systematic review and meta-analysis.
Vartolomei MD; Porav-Hodade D; Ferro M; Mathieu R; Abufaraj M; Foerster B; Kimura S; Shariat SF
Urol Oncol; 2018 Sep; 36(9):389-399. PubMed ID: 29884342
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of preoperative neutrophil-to-lymphocyte ratio in histological variants of non-muscle-invasive bladder cancer.
Li DX; Wang XM; Tang Y; Yang YB; Feng DC; Li A; Zhang FC; Bai YJ; Han P
Investig Clin Urol; 2021 Nov; 62(6):641-649. PubMed ID: 34729964
[TBL] [Abstract][Full Text] [Related]
7. Identification of the best complete blood count-based predictors for bladder cancer outcomes in patients undergoing radical cystectomy.
Bhindi B; Hermanns T; Wei Y; Yu J; Richard PO; Wettstein MS; Templeton A; Li K; Sridhar SS; Jewett MA; Fleshner NE; Zlotta AR; Kulkarni GS
Br J Cancer; 2016 Jan; 114(2):207-12. PubMed ID: 26657651
[TBL] [Abstract][Full Text] [Related]
8. Neutrophil to lymphocyte ratio, a biomarker in non-muscle invasive bladder cancer: a single-institutional longitudinal study.
Favilla V; Castelli T; Urzì D; Reale G; Privitera S; Salici A; Russo GI; Cimino S; Morgia G
Int Braz J Urol; 2016; 42(4):685-93. PubMed ID: 27564278
[TBL] [Abstract][Full Text] [Related]
9. Neutrophil-to-lymphocyte ratio as a detection marker of tumor recurrence in patients with muscle-invasive bladder cancer after radical cystectomy.
Morizawa Y; Miyake M; Shimada K; Hori S; Tatsumi Y; Nakai Y; Anai S; Tanaka N; Konishi N; Fujimoto K
Urol Oncol; 2016 Jun; 34(6):257.e11-7. PubMed ID: 27038696
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Value of the Neutrophil-to-Lymphocyte Ratio in Nonmuscle-Invasive Bladder Cancer Treated with GreenLight Laser Vaporization.
Luo F; Ma C; Wu J; Li J
Photobiomodul Photomed Laser Surg; 2019 May; 37(5):312-317. PubMed ID: 31084565
[No Abstract] [Full Text] [Related]
11. Neutrophil-to-lymphocyte ratio predicts progression and recurrence of non-muscle-invasive bladder cancer.
Mano R; Baniel J; Shoshany O; Margel D; Bar-On T; Nativ O; Rubinstein J; Halachmi S
Urol Oncol; 2015 Feb; 33(2):67.e1-7. PubMed ID: 25060672
[TBL] [Abstract][Full Text] [Related]
12. Neutrophil-to-lymphocyte ratio as a bladder cancer biomarker: Assessing prognostic and predictive value in SWOG 8710.
Ojerholm E; Smith A; Hwang WT; Baumann BC; Tucker KN; Lerner SP; Mamtani R; Boursi B; Christodouleas JP
Cancer; 2017 Mar; 123(5):794-801. PubMed ID: 27787873
[TBL] [Abstract][Full Text] [Related]
13. Pretreatment neutrophil to lymphocyte ratio in determining the prognosis of head and neck cancer: a meta-analysis.
Yu Y; Wang H; Yan A; Wang H; Li X; Liu J; Li W
BMC Cancer; 2018 Apr; 18(1):383. PubMed ID: 29618336
[TBL] [Abstract][Full Text] [Related]
14. Pretreatment neutrophil-to-lymphocyte ratio is associated with advanced pathologic tumor stage and increased cancer-specific mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomy.
Viers BR; Boorjian SA; Frank I; Tarrell RF; Thapa P; Karnes RJ; Thompson RH; Tollefson MK
Eur Urol; 2014 Dec; 66(6):1157-64. PubMed ID: 24630414
[TBL] [Abstract][Full Text] [Related]
15. Prognostic role of pretreatment blood neutrophil-to-lymphocyte ratio in advanced cancer survivors: A systematic review and meta-analysis of 66 cohort studies.
Mei Z; Shi L; Wang B; Yang J; Xiao Z; Du P; Wang Q; Yang W
Cancer Treat Rev; 2017 Jul; 58():1-13. PubMed ID: 28602879
[TBL] [Abstract][Full Text] [Related]
16. Value of Preoperative Neutrophil-to-Lymphocyte Ratio in Predicting Prognosis of Surgically Resectable Urinary Cancers: Systematic Review and Meta-Analysis.
Wang Z; Wang X; Wang WD; Zheng GY; Guo H; Zhang YS
Chin Med Sci J; 2020 Sep; 35(3):262-271. PubMed ID: 32972504
[TBL] [Abstract][Full Text] [Related]
17. Preoperative neutrophil to lymphocyte ratio improves recurrence prediction of non-muscle invasive bladder cancer.
Getzler I; Bahouth Z; Nativ O; Rubinstein J; Halachmi S
BMC Urol; 2018 Oct; 18(1):90. PubMed ID: 30348146
[TBL] [Abstract][Full Text] [Related]
18. Neutrophil-to-lymphocyte ratio as prognostic indicator in gastrointestinal cancers: a systematic review and meta-analysis.
Bowen RC; Little NAB; Harmer JR; Ma J; Mirabelli LG; Roller KD; Breivik AM; Signor E; Miller AB; Khong HT
Oncotarget; 2017 May; 8(19):32171-32189. PubMed ID: 28418870
[TBL] [Abstract][Full Text] [Related]
19. The prognostic value of preoperative NLR, d-NLR, PLR and LMR for predicting clinical outcome in surgical colorectal cancer patients.
Ying HQ; Deng QW; He BS; Pan YQ; Wang F; Sun HL; Chen J; Liu X; Wang SK
Med Oncol; 2014 Dec; 31(12):305. PubMed ID: 25355641
[TBL] [Abstract][Full Text] [Related]
20. Low Pretreatment Neutrophil-to-Lymphocyte Ratio Predicts for Good Outcomes in Patients Receiving Neoadjuvant Chemotherapy Before Radical Cystectomy for Muscle Invasive Bladder Cancer.
Buisan O; Orsola A; Areal J; Font A; Oliveira M; Martinez R; Ibarz L
Clin Genitourin Cancer; 2017 Feb; 15(1):145-151.e2. PubMed ID: 27364982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
